|
| Roche events | Current |
|
|
9th European AIDS Conference (EACS), Warsaw, Poland, 25-29 October 2003
|
|
1. Welcome and introduction, Julio Montaner |
|
|
2. From discord to harmony:
Redefining treatment for HIV-HCV co-infected patients, Renato Maserati |
|
|
3. Amplified HAART: Novel treatment strategies using saquinavir as part of boosted and double-boosted regimens, David Cooper |
|
|
4. HAART beats: Achieving long-term success with enfuvirtide, Julio Montaner
|
|
|
5. Sound advice: Maximizing patient benefit from FUZEON, Gerene Larson |
|
|
|
2nd IAS Conference on HIV Pathogenesis and Treatment, Paris, France, 13-16 July 2003
|
|
Masters of ART - Roche Satellite Symposium Invitation |
|
|
View Symposium Abstract Book |
|
|
1. Introduction by Francoise Brun-Vezinet |
|
|
2. The role of nelfinavir in HIV/HCV co-infected patients, Doug Dieterich |
|
|
3. Novel treatment strategies using boosted saquinavir, Cal Cohen |
|
|
4. Advancing protease inhibitor-treatment to meet changing patient needs, Anton Pozniak |
|
|
5. New analyses to further define the clinical profile of enfuvirtide, Joep Lange |
|
|
6. Achieving optimal patient outcome with enfuvirtide, James Witek
|
|
|
7. Final remarks and close, Anton Pozniak |
|
|
|
6th International Congress on Drug Therapy in HIV Infection (HIV6) Glasgow, 2002 |
|
1. Invitation to Roche Satellite Symposium |
|
|
2. Roche Satellite Symposium Abstract Book |
|
|
3. Introduction by Ceppy Merry |
|
|
4. A tailored fit - Viracept and the requirements of defined patient populations - Sharon Walmsley |
|
|
5. Measuring up - Clinical performance of boosted saquinavir in diverse treatment groups - David Cooper |
|
|
6. Will it suit me? The importance of safety and patient acceptance to long-term success - Anton Pozniak |
|
|
|
XIV International AIDS Conference, Barcelona 7-12 July 2002
|
|
View Symposium Abstract Book - From ART to SMART |
|
|
View Symposium Abstract Book - Pushing the Limits |
|
|
|
ART to SMART Symposium Slides, Barcelona 7 July 2002 |
|
Fortovase: Maximizing power, improving safety, Sharon Walmsley |
|
|
Power to the people, Jonathan Schapiro |
|
|
Safety and long-term success of HAART, Mike Youle |
|
|
Viracept: Confidence of long-term control, Joseph Gathe |
|
|
|
Pushing the Limits Symposium Slides, Barcelona, 9 July 2002 |
|
Going the difference: extending the usefulness of RT/PCR, Thomas Myers |
|
|
Performance indicators: the predictive and clinical value of HIV-1 quantitive proviral DNA assays, Christine Rouzioux |
|
|
Raising the standards: improving the sensitivity of viral load testing, Brooks Jackson |
|
|
Tracking global diversity: viral subtypes and their implications for HIV viral load and resistance testing, Clive Loveday |
|
|
|
SMART Living, Lausanne, 19 - 21 April 2002 |
|
Saquinavir Newsletter: Recent developments in antiretroviral therapy |
|
|
Viracept Newsletter: Selecting and optimizing first line therapy |
|
|
|
Fifth International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000: SMART Living - Strategic Moves in AntiRetroviral Therapy |
|
View Satellite Symposium Abstract Booklet |
|
|
|
XIII International AIDS Conference, Durban 9-14 July 2000 |
|
View Satellite Symposium Abstract Booklet |
|
